Metformin (off-label for weight management) Metformin is the most widely prescribed diabetes medication in the world, and while it is not FDA-approved for weight loss, it consistently produces modest weight reduction of 2-5% in clinical studies
The altered skin sensation has not been reported in the PIONEER-PLUS study or with injectable semaglutide 2.4 mg and its aetiology will need to be explored further in future studies
Retatrutide is a once-weekly weight loss injection that combines the actions of three key metabolic hormones: GLP-1 (helps you feel full and keeps blood sugar in balance) GIP (supports insulin release and helps your body process food for energy) Glucagon (tells your body to burn fat for energy) This triple G mechanism sets it apart from Wegovy, which targets one hormone, and Mounjaro, which targets two
Expanding Indications: Beyond Obesity and Diabetes The GLP-1 drug pipeline in 2026 reaches well beyond weight management and glycaemic control
However, your results will differ based on which treatment plan you pick
Sandra Christensen, Email: [email protected]
